Clinical Trials

Chronic Obstructive Pulmonary Disease (COPD)

Posted on 9/23/2020
Chronic obstructive pulmonary disease (COPD) is a highly prevalent disease, associated with significant economic burden, and for which available standard-of-care therapies show insufficient treatment effect on symptoms, lung function, exacerbations and long term progression of the disease.

This study is designed to investigate the efficacy and safety profile of dupilumab over one year in patients with COPD who are in need of an additional treatment added to their current management and to assess the effect of the study drug on lung function, exacerbations and quality of life in patients with COPD.  The safety and tolerability of the study drug will also be monitored as part of the study.

The study will last about 68 weeks and you will have 19 visits to the clinic.  You will receive either the study drug or placebo (a substance that looks exactly like the study drug but has no active medicine).

You may qualify if you:
  • Are a current or former smoker with a smoking history of >10 pack-years
  • Mod-severe COPD for more than 12 months
  • History of signs/symptoms of chronic bronchitis (chronic productive cough) for 3 months in the past year
  • Do not have a history or diagnosis of asthma
  • Do not need oxygen more than 12 hours per day

There will be no charge for participating in the study.  The study medication, study materials and study specific visits will be provided at no charge to you or your insurance company. 

If you qualify and decide to participate you will be compensated for your time and travel while participating in the study.  

You will receive $75 for each study visit.  In the event you decide to have the study drug administered in the clinic, you will also receive $25 per visit for those administration visits.

Call our office for more information - (903) 238-8854
What Our Research Patients are Saying
"Last January I had to begin taking insulin for my diabetes. It was life changing for me. I had always been afraid of starting insulin. However, when I qualified for the diabetes clinical trial, it helped me accept this change in my life. The Research Coordinators are the very best you could ask for. They explained everything and let me know what to expect. I could never have controlled my diabetes if it hadn't been for this research program, the research staff and the study doctor. I would recommend participating in a research trial to anyone who has diabetes. It and the research staff are a godsend."
~ C.D

Contact Form


  
DCOL of Longview